zbhtet personal page - To The Moon

zbhtet

No personal profile

6Follow

0Followers

0Topic

0Badge

2022-02-25

Pls like

Sorry, the original content has been removed

2022-02-18

Pls like

Sorry, the original content has been removed

2022-02-07

Pls like

Selling Seems Overdone for Sea Stock

2022-02-07

Pls like

Sorry, the original content has been removed

2022-02-01

Pls like

Is Palantir's Stock Too Cheap? Guy Adami Thinks So

2022-02-01

Pls like

Are Warren Buffett's 3 Cheapest Stocks Screaming Buys?

2022-01-31

Pls like

Boeing shares rose more than 2% in morning trading

2021-12-23

Like

Wall St mints strong gains on rosy economic data, encouraging Omicron update

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4088495159199840","uuid":"4088495159199840","gmtCreate":1625557406532,"gmtModify":1625557406532,"name":"zbhtet","pinyin":"zbhtet","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":6,"tweetSize":9,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.12.17","exceedPercentage":"93.08%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.04.05","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.34%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":6,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":1,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":9030459042,"gmtCreate":1645794189931,"gmtModify":1676534064849,"author":{"id":"4088495159199840","authorId":"4088495159199840","name":"zbhtet","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4088495159199840","idStr":"4088495159199840"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9030459042","repostId":"1185987372","repostType":2,"isVote":1,"tweetType":1,"viewCount":642,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9094490109,"gmtCreate":1645198091712,"gmtModify":1676534008360,"author":{"id":"4088495159199840","authorId":"4088495159199840","name":"zbhtet","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4088495159199840","idStr":"4088495159199840"},"themes":[],"htmlText":"Pls like&nbsp;","listText":"Pls like&nbsp;","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9094490109","repostId":"1197876155","repostType":2,"isVote":1,"tweetType":1,"viewCount":685,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9098751730,"gmtCreate":1644241406257,"gmtModify":1676533903092,"author":{"id":"4088495159199840","authorId":"4088495159199840","name":"zbhtet","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4088495159199840","idStr":"4088495159199840"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9098751730","repostId":"1149534909","repostType":2,"repost":{"id":"1149534909","kind":"news","pubTimestamp":1644212617,"share":"https://ttm.financial/m/news/1149534909?lang=&edition=fundamental","pubTime":"2022-02-07 13:43","market":"us","language":"en","title":"Selling Seems Overdone for Sea Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=1149534909","media":"TipRanks","summary":"Sea Limited (SE) stock was trading at $40 at the beginning of 2020. The stock surged to highs of $37","content":"<div>\n<p>Sea Limited (SE) stock was trading at $40 at the beginning of 2020. The stock surged to highs of $372 by October 2021. A rally of more than 800% within 24 months was likely to be followed by a ...</p>\n\n<a href=\"https://www.tipranks.com/news/article/selling-seems-overdone-for-sea-stock/\">Web Link</a>\n\n</div>\n","source":"lsy1606183248679","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Selling Seems Overdone for Sea Stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSelling Seems Overdone for Sea Stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-07 13:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.tipranks.com/news/article/selling-seems-overdone-for-sea-stock/><strong>TipRanks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Sea Limited (SE) stock was trading at $40 at the beginning of 2020. The stock surged to highs of $372 by October 2021. A rally of more than 800% within 24 months was likely to be followed by a ...</p>\n\n<a href=\"https://www.tipranks.com/news/article/selling-seems-overdone-for-sea-stock/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SE":"Sea Ltd"},"source_url":"https://www.tipranks.com/news/article/selling-seems-overdone-for-sea-stock/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1149534909","content_text":"Sea Limited (SE) stock was trading at $40 at the beginning of 2020. The stock surged to highs of $372 by October 2021. A rally of more than 800% within 24 months was likely to be followed by a correction. However, the decline has been greater than expected and SE stock currently trades at $155.I believe that the stock is attractive after a big correction, and the worst of the downside is over. Investors can consider fresh exposure to the stock at current levels.It’s worth adding here that Sea Limited continues to deliver robust top-line growth. However, besides the profit booking factor, cash burn is one reason for the sharp decline in the stock. The concern seems to be temporary and provides investors with an entry opportunity.Singapore-based Sea Limited is an internet and mobile platform company, which provides mobile digital content, e-commerce, gaming services and payment platforms.Robust Growth to SustainFor Q3 2021, Sea reported revenue growth of 121.8% on a year-on-year basis to $2.7 billion.Revenue growth for the company has been above 100% on a consistent basis. This explains the multi-fold returns before the current correction.It’s also very likely that robust growth will sustain for Sea in the coming years.A key reason is the company’s strong presence in the Southeast Asian markets. Reports suggest that Southeast Asia added 70 million shoppers since the beginning of the COVID-19 pandemic.It’s also estimated that the number of online shoppers in Southeast Asia will reach 380 million by 2026. Indonesia is likely to be the leading market, followed by Vietnam and Thailand.Clearly, Sea Limited has positive industry tailwinds and this will ensure that healthy growth sustains.An important point to mention here is that as of Q3 2021, the company reported cash and equivalents of $11.12 billion. The company therefore has robust financial flexibility to pursue aggressive expansion and investment in marketing.Cash Burn will Decline with Operating LeverageWhen we look deeper into the company’s results, we can identify two primary segments that are potential cash flow drivers.For Q3 2021, the Digital Entertainment segment reported bookings of $1.2 billion. On a year-on-year basis, bookings were higher by 29.2%. Further, the Digital Entertainment segment reported a positive EBITDA of $715.1 million. Therefore, the segment has a healthy adjusted EBITDA margin.On the other hand, the E-commerce segment revenue growth was 134.4% on a year-on-year basis. The segment, however, reported negative EBITDA of $683.3 million. EBITDA level losses have sustained for the E-commerce segment and that’s one concern among market participants.However, the key point to note is as follows – Amazon (AMZN), Alibaba (BABA) and JD.com (JD) are few examples of e-commerce businesses that are already cash flow machines. There is no reason to believe that Sea Limited can’t replicate a similar business model.With more than 100% revenue growth in the e-commerce segment, the company is positioned to deliver improved EBITDA margin. Once the digital Entertainment and E-commerce segments report positive EBITDA, SE stock will rally.Moreover, the company’s Digital Financial Services growth has also been robust. For Q3 2021, Sea reported $4.6 billion in mobile wallet payment volume. On a year-on-year basis, payment volumes were higher by 111%. With 39.3 million quarterly paying users, the Digital Financial Services segment is another potential game-changer.Sea Limited, therefore, has three business segments that are on a healthy growth trajectory. Geographical expansion for e-commerce is also likely in the next few years. This will ensure that the growth trajectory sustains. The company’s mobile game already has presence in Latin America and India.Wall Street’s TakeTurning to Wall Street, Sea Limited has a Strong Buy consensus rating, based on eight Buys and one Hold ratings assigned in the past three months. The average Sea Limited price target of $322.0 implies 107.8% upside potential.Bottom LineSea Limited has the catalysts of positive industry tailwinds coupled with robust growth. Furthermore, the company has ample cash buffer to navigate the cash burn. With operating leverage in the e-commerce segment, SE likely to be a long-term value creator.The correction in SE stock is therefore a good opportunity to accumulate. In all probability, the downside is capped from current levels and the upside potential is meaningful.","news_type":1},"isVote":1,"tweetType":1,"viewCount":800,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9098751610,"gmtCreate":1644241283547,"gmtModify":1676533903082,"author":{"id":"4088495159199840","authorId":"4088495159199840","name":"zbhtet","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4088495159199840","idStr":"4088495159199840"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9098751610","repostId":"2209320195","repostType":2,"isVote":1,"tweetType":1,"viewCount":936,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9093704382,"gmtCreate":1643699447551,"gmtModify":1676533846050,"author":{"id":"4088495159199840","authorId":"4088495159199840","name":"zbhtet","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4088495159199840","idStr":"4088495159199840"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9093704382","repostId":"1197842729","repostType":4,"repost":{"id":"1197842729","kind":"news","pubTimestamp":1643674410,"share":"https://ttm.financial/m/news/1197842729?lang=&edition=fundamental","pubTime":"2022-02-01 08:13","market":"us","language":"en","title":"Is Palantir's Stock Too Cheap? Guy Adami Thinks So","url":"https://stock-news.laohu8.com/highlight/detail?id=1197842729","media":"Benzinga","summary":"Palantir Technologies Inc is down more than 60% over the past year and nearly 25% this month alone. ","content":"<html><head></head><body><p>Palantir Technologies Inc is down more than 60% over the past year and nearly 25% this month alone. That&#39;s a pretty downbeat start to 2022 for the data analytics company, but Private Advisor Group&#39;s Guy Adami thinks patient investors will be rewarded.</p><p>&#34;Data is the new oil,&#34; Adami said Monday on CNBC&#39;s &#34;Fast Money.&#34;</p><p>&#34;They&#39;re in the midst of it ... and I just don&#39;t think people fully understand.&#34;</p><p>He noted the stock was off to a great start in 2021 but ended up getting caught up in the WallStreetBets frenzy. Members of the popular subreddit banded together and sent stocks such as GameStop Corp. and AMC Entertainment Holdings Inc soaring.</p><p>Adami thinks Palantir&#39;s involvement was detrimental for the stock longer-term, which seems clear when looking at its performance over the past year.</p><p>He expects the company to expand its offerings for medium-sized businesses, which will ultimately improve margins.</p><p>&#34;I think this stock with a 13 handle is just too cheap in this environment,&#34; Adami said.</p><p>From Last Week: This Is What Whales Are Betting On Palantir Technologies</p><p>PLTR Price Action: Palantir has traded as low as $11.75 and as high as $39.22 over a 52-week period.</p><p>The stock was up 1.09% in after-hours trading at $13.86 Monday at publication.</p></body></html>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Palantir's Stock Too Cheap? Guy Adami Thinks So</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Palantir's Stock Too Cheap? Guy Adami Thinks So\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-01 08:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/trading-ideas/long-ideas/22/01/25326401/is-palantirs-stock-too-cheap-guy-adami-thinks-so><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Palantir Technologies Inc is down more than 60% over the past year and nearly 25% this month alone. That's a pretty downbeat start to 2022 for the data analytics company, but Private Advisor Group's ...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/long-ideas/22/01/25326401/is-palantirs-stock-too-cheap-guy-adami-thinks-so\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://www.benzinga.com/trading-ideas/long-ideas/22/01/25326401/is-palantirs-stock-too-cheap-guy-adami-thinks-so","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197842729","content_text":"Palantir Technologies Inc is down more than 60% over the past year and nearly 25% this month alone. That's a pretty downbeat start to 2022 for the data analytics company, but Private Advisor Group's Guy Adami thinks patient investors will be rewarded.\"Data is the new oil,\" Adami said Monday on CNBC's \"Fast Money.\"\"They're in the midst of it ... and I just don't think people fully understand.\"He noted the stock was off to a great start in 2021 but ended up getting caught up in the WallStreetBets frenzy. Members of the popular subreddit banded together and sent stocks such as GameStop Corp. and AMC Entertainment Holdings Inc soaring.Adami thinks Palantir's involvement was detrimental for the stock longer-term, which seems clear when looking at its performance over the past year.He expects the company to expand its offerings for medium-sized businesses, which will ultimately improve margins.\"I think this stock with a 13 handle is just too cheap in this environment,\" Adami said.From Last Week: This Is What Whales Are Betting On Palantir TechnologiesPLTR Price Action: Palantir has traded as low as $11.75 and as high as $39.22 over a 52-week period.The stock was up 1.09% in after-hours trading at $13.86 Monday at publication.","news_type":1},"isVote":1,"tweetType":1,"viewCount":301,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9093705452,"gmtCreate":1643699404873,"gmtModify":1676533846051,"author":{"id":"4088495159199840","authorId":"4088495159199840","name":"zbhtet","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4088495159199840","idStr":"4088495159199840"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9093705452","repostId":"2207226382","repostType":4,"repost":{"id":"2207226382","kind":"highlight","pubTimestamp":1643674838,"share":"https://ttm.financial/m/news/2207226382?lang=&edition=fundamental","pubTime":"2022-02-01 08:20","market":"us","language":"en","title":"Are Warren Buffett's 3 Cheapest Stocks Screaming Buys?","url":"https://stock-news.laohu8.com/highlight/detail?id=2207226382","media":"Motley Fool","summary":"Bristol Myers Squibb, General Motors, and Teva Pharmaceutical Industries are three dirt cheap Buffett stocks worth buying right now.","content":"<html><head></head><body><p><b>Berkshire Hathaway</b> CEO and world-renowned superinvestor Warren Buffett is a dyed-in-the-wool value investor. Buffett&#39;s core strategy centers around buying shares of companies with remarkably strong underlying businesses (deep competitive moats, global brand recognition, reliable and growing free cash flows, etc.), yet whose shares trade at a discount relative to their intrinsic value.</p><p>And this value-oriented approach has certainly served Buffett well during his tenure as Berkshire CEO. Since taking the reins of the diversified holding company 56-plus years ago, Berkshire&#39;s stock has delivered total returns on capital in excess of 6,450%. In fact, $10,000 invested in Berkshire stock at the time Buffett become CEO would be worth approximately $654,890 today.</p><p><img src=\"https://static.tigerbbs.com/6d9a90b9030efaa614666da83153f552\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><p>Image source: Getty Images.</p><p>Berkshire&#39;s various holdings aren&#39;t all top value stocks, however. The reality of the situation is that Berkshire, along with most other mega-funds, often gets special incentives, such as an elevated dividend yield, to buy shares of a company in bulk.</p><p>As a result, the value proposition offered to large holding firms like Berkshire is often drastically different than the <a href=\"https://laohu8.com/S/AONE.U\">one</a> available to ordinary retail investors via a company&#39;s common stock. Retail investors, in turn, shouldn&#39;t necessarily buy shares of a Buffett stock simply because it looks cheap based on a classic valuation metric such as price to earnings, price to book, or price to sales.</p><p>Armed with this insight, let&#39;s break down whether Berkshire&#39;s three cheapest holdings, based on their forward-looking price-to-earnings ratios, are bona fide value stocks suitable for retail investors.</p><h2>A top big pharma stock</h2><p>At a hair under eight times forward earnings, the pharmaceutical giant <b>Bristol Myers Squibb</b> (NYSE:BMY) is Berkshire&#39;s third-cheapest stock holding at the moment. Bristol&#39;s shares have essentially treaded water over the past year due to its three top-selling medications (Eliquis, Opdivo, and Revlimid) losing market exclusivity this decade.</p><p>While this wave of patent expirations may be worrisome at first glance, the drugmaker does have a solid plan in place to not only offset these future sales declines, but to keep its top line humming along all the way out to 2030. Namely, Bristol has multiple new drug launches planned over the next few years, several of which are for potential blockbuster medications.</p><p>The long and short of it is that this isn&#39;t Bristol&#39;s first bout with the patent cliff. The company has lost market exclusivity for scores of blockbuster medications in the past. Yet it has always managed to hit on new growth products to create enormous value for long-term shareholders. Value-oriented investors, in turn, shouldn&#39;t hesitate to capitalize on the market&#39;s overreaction to the pharma titan&#39;s ongoing portfolio churn.</p><h2>A potential sleeping giant</h2><p>Shares of the large-cap automaker <b>General Motors</b> (NYSE:GM) are currently trading at 7.43 times forward earnings. That&#39;s good for second place on Berkshire&#39;s list of cheapest stock holdings. The auto giant&#39;s stock has stagnated over the last year in response to the rise of electric vehicles, the market-wide disinterest in classic value stocks, and the upcoming interest rate hikes by the Federal Reserve that will surely make monthly payments more expensive for most car buyers.</p><p>General Motors, though, may have some magic in it that the market has yet to fully appreciate. Last summer, the car giant announced an intriguing plan to invest heavily in electric vehicles, autonomous vehicles, and batteries. With a global commercial footprint and rock solid branding power, General Motors could prove to be a formidable competitor in these high-growth segments of the market.</p><p>That said, General Motors&#39; latent value proposition, albeit massive, may take a few years to win over investors. So, while this auto stock does come across as a compelling buy, this Buffett value stock will likely require a multi-year holding period to realize its full potential.</p><h2>Buffett&#39;s cheapest stock holding</h2><p>With its shares trading at 3.12 times forward earnings, Israeli generic and branded drug giant <b>Teva Pharmaceutical Industries</b> (NYSE:TEVA) is Berkshire&#39;s cheapest stock holding by a wide margin.</p><p>The drugmaker&#39;s shares have lost three-quarters of their value over the last five years due to a series of unfortunate events. Specifically, Teva took on far too much debt to acquire Actavis&#39; generic drug portfolio back in 2016, it didn&#39;t have another franchise-level medication waiting in the wings to replace the multiple sclerosis drug Copaxone following its loss of exclusivity, and it has been embroiled in a string of costly lawsuits.</p><p>Teva&#39;s long-awaited turnaround, though, does seem to be coming into focus now, thanks to three key developments. First, the company has slowly built a well-rounded product portfolio that should return it to sustainable levels of growth soon. Second, its various legal problems ought to be resolved in the not-so-distant future. Third, Teva&#39;s ongoing deleveraging process has significantly improved the health of its balance sheet over the past few years. Teva&#39;s stock thus appears poised for a major rebound, perhaps as soon as this year.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Are Warren Buffett's 3 Cheapest Stocks Screaming Buys?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAre Warren Buffett's 3 Cheapest Stocks Screaming Buys?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-01 08:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/31/are-warren-buffetts-3-cheapest-stocks-screaming-bu/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Berkshire Hathaway CEO and world-renowned superinvestor Warren Buffett is a dyed-in-the-wool value investor. Buffett's core strategy centers around buying shares of companies with remarkably strong ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/31/are-warren-buffetts-3-cheapest-stocks-screaming-bu/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4555":"新能源车","BK4099":"汽车制造商","BK4007":"制药","BK4532":"文艺复兴科技持仓","BRK.B":"伯克希尔B","BMY":"施贵宝","BK4566":"资本集团","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4557":"大麻股","BRK.A":"伯克希尔","BK4176":"多领域控股","GM":"通用汽车","BK4534":"瑞士信贷持仓","BK4559":"巴菲特持仓","BK4561":"索罗斯持仓","TEVA":"梯瓦制药","BK4550":"红杉资本持仓"},"source_url":"https://www.fool.com/investing/2022/01/31/are-warren-buffetts-3-cheapest-stocks-screaming-bu/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2207226382","content_text":"Berkshire Hathaway CEO and world-renowned superinvestor Warren Buffett is a dyed-in-the-wool value investor. Buffett's core strategy centers around buying shares of companies with remarkably strong underlying businesses (deep competitive moats, global brand recognition, reliable and growing free cash flows, etc.), yet whose shares trade at a discount relative to their intrinsic value.And this value-oriented approach has certainly served Buffett well during his tenure as Berkshire CEO. Since taking the reins of the diversified holding company 56-plus years ago, Berkshire's stock has delivered total returns on capital in excess of 6,450%. In fact, $10,000 invested in Berkshire stock at the time Buffett become CEO would be worth approximately $654,890 today.Image source: Getty Images.Berkshire's various holdings aren't all top value stocks, however. The reality of the situation is that Berkshire, along with most other mega-funds, often gets special incentives, such as an elevated dividend yield, to buy shares of a company in bulk.As a result, the value proposition offered to large holding firms like Berkshire is often drastically different than the one available to ordinary retail investors via a company's common stock. Retail investors, in turn, shouldn't necessarily buy shares of a Buffett stock simply because it looks cheap based on a classic valuation metric such as price to earnings, price to book, or price to sales.Armed with this insight, let's break down whether Berkshire's three cheapest holdings, based on their forward-looking price-to-earnings ratios, are bona fide value stocks suitable for retail investors.A top big pharma stockAt a hair under eight times forward earnings, the pharmaceutical giant Bristol Myers Squibb (NYSE:BMY) is Berkshire's third-cheapest stock holding at the moment. Bristol's shares have essentially treaded water over the past year due to its three top-selling medications (Eliquis, Opdivo, and Revlimid) losing market exclusivity this decade.While this wave of patent expirations may be worrisome at first glance, the drugmaker does have a solid plan in place to not only offset these future sales declines, but to keep its top line humming along all the way out to 2030. Namely, Bristol has multiple new drug launches planned over the next few years, several of which are for potential blockbuster medications.The long and short of it is that this isn't Bristol's first bout with the patent cliff. The company has lost market exclusivity for scores of blockbuster medications in the past. Yet it has always managed to hit on new growth products to create enormous value for long-term shareholders. Value-oriented investors, in turn, shouldn't hesitate to capitalize on the market's overreaction to the pharma titan's ongoing portfolio churn.A potential sleeping giantShares of the large-cap automaker General Motors (NYSE:GM) are currently trading at 7.43 times forward earnings. That's good for second place on Berkshire's list of cheapest stock holdings. The auto giant's stock has stagnated over the last year in response to the rise of electric vehicles, the market-wide disinterest in classic value stocks, and the upcoming interest rate hikes by the Federal Reserve that will surely make monthly payments more expensive for most car buyers.General Motors, though, may have some magic in it that the market has yet to fully appreciate. Last summer, the car giant announced an intriguing plan to invest heavily in electric vehicles, autonomous vehicles, and batteries. With a global commercial footprint and rock solid branding power, General Motors could prove to be a formidable competitor in these high-growth segments of the market.That said, General Motors' latent value proposition, albeit massive, may take a few years to win over investors. So, while this auto stock does come across as a compelling buy, this Buffett value stock will likely require a multi-year holding period to realize its full potential.Buffett's cheapest stock holdingWith its shares trading at 3.12 times forward earnings, Israeli generic and branded drug giant Teva Pharmaceutical Industries (NYSE:TEVA) is Berkshire's cheapest stock holding by a wide margin.The drugmaker's shares have lost three-quarters of their value over the last five years due to a series of unfortunate events. Specifically, Teva took on far too much debt to acquire Actavis' generic drug portfolio back in 2016, it didn't have another franchise-level medication waiting in the wings to replace the multiple sclerosis drug Copaxone following its loss of exclusivity, and it has been embroiled in a string of costly lawsuits.Teva's long-awaited turnaround, though, does seem to be coming into focus now, thanks to three key developments. First, the company has slowly built a well-rounded product portfolio that should return it to sustainable levels of growth soon. Second, its various legal problems ought to be resolved in the not-so-distant future. Third, Teva's ongoing deleveraging process has significantly improved the health of its balance sheet over the past few years. Teva's stock thus appears poised for a major rebound, perhaps as soon as this year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":519,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9093254942,"gmtCreate":1643644785529,"gmtModify":1676533839745,"author":{"id":"4088495159199840","authorId":"4088495159199840","name":"zbhtet","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4088495159199840","idStr":"4088495159199840"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9093254942","repostId":"1173569070","repostType":4,"repost":{"id":"1173569070","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1643641805,"share":"https://ttm.financial/m/news/1173569070?lang=&edition=fundamental","pubTime":"2022-01-31 23:10","market":"us","language":"en","title":"Boeing shares rose more than 2% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1173569070","media":"Tiger Newspress","summary":"Boeing shares rose more than 2% in morning trading.Boeing Co    is set to sign a launch order from Q","content":"<html><head></head><body><p>Boeing shares rose more than 2% in morning trading.<img src=\"https://static.tigerbbs.com/8b4bcff3932492fe06a1494202fb6d1e\" tg-width=\"702\" tg-height=\"594\" width=\"100%\" height=\"auto\"/>Boeing Co    is set to sign a launch order from Qatar Airways for a new freighter version of its 777X passenger jet on Monday, in a Washington ceremony coinciding with a visit by the Gulf state&#39;s ruling emir, U.S. officials said.</p><p>Reuters reported last week that the U.S. planemaker was in advanced negotiations with the Gulf carrier for around 34 of the planned twin-engined freighters in a deal provisionally estimated to be worth $14 billion at list prices.</p><p>Qatar Airways has publicly said it is interested in buying up to 50 new-generation freighters, with the higher figure expected to include options that could lead to top-up purchases in the future.</p><p>It may also bridge to the new cargo version of the upgraded 777X with a handful of extra current-generation 777 freighters.</p><p>The deal, which could effectively kickstart development of the new freighter, is expected to be signed at a White House ceremony at 12:30 pm local (1630 GMT), the officials said.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Boeing shares rose more than 2% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBoeing shares rose more than 2% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-31 23:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Boeing shares rose more than 2% in morning trading.<img src=\"https://static.tigerbbs.com/8b4bcff3932492fe06a1494202fb6d1e\" tg-width=\"702\" tg-height=\"594\" width=\"100%\" height=\"auto\"/>Boeing Co    is set to sign a launch order from Qatar Airways for a new freighter version of its 777X passenger jet on Monday, in a Washington ceremony coinciding with a visit by the Gulf state&#39;s ruling emir, U.S. officials said.</p><p>Reuters reported last week that the U.S. planemaker was in advanced negotiations with the Gulf carrier for around 34 of the planned twin-engined freighters in a deal provisionally estimated to be worth $14 billion at list prices.</p><p>Qatar Airways has publicly said it is interested in buying up to 50 new-generation freighters, with the higher figure expected to include options that could lead to top-up purchases in the future.</p><p>It may also bridge to the new cargo version of the upgraded 777X with a handful of extra current-generation 777 freighters.</p><p>The deal, which could effectively kickstart development of the new freighter, is expected to be signed at a White House ceremony at 12:30 pm local (1630 GMT), the officials said.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BA":"波音"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173569070","content_text":"Boeing shares rose more than 2% in morning trading.Boeing Co    is set to sign a launch order from Qatar Airways for a new freighter version of its 777X passenger jet on Monday, in a Washington ceremony coinciding with a visit by the Gulf state's ruling emir, U.S. officials said.Reuters reported last week that the U.S. planemaker was in advanced negotiations with the Gulf carrier for around 34 of the planned twin-engined freighters in a deal provisionally estimated to be worth $14 billion at list prices.Qatar Airways has publicly said it is interested in buying up to 50 new-generation freighters, with the higher figure expected to include options that could lead to top-up purchases in the future.It may also bridge to the new cargo version of the upgraded 777X with a handful of extra current-generation 777 freighters.The deal, which could effectively kickstart development of the new freighter, is expected to be signed at a White House ceremony at 12:30 pm local (1630 GMT), the officials said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":647,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9000588762,"gmtCreate":1640231629985,"gmtModify":1676533510353,"author":{"id":"4088495159199840","authorId":"4088495159199840","name":"zbhtet","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4088495159199840","idStr":"4088495159199840"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000588762","repostId":"2193113147","repostType":4,"repost":{"id":"2193113147","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640213688,"share":"https://ttm.financial/m/news/2193113147?lang=&edition=fundamental","pubTime":"2021-12-23 06:54","market":"us","language":"en","title":"Wall St mints strong gains on rosy economic data, encouraging Omicron update","url":"https://stock-news.laohu8.com/highlight/detail?id=2193113147","media":"Reuters","summary":"* Tesla jumps as CEO Musk says he has sold 'enough' stock. * Pfizer rises as oral COVID-19 pill wins approval. Dec 22  - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.The S&P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of","content":"<p>* Consumer confidence index increases in December</p>\n<p>* U.S. Q3 economic growth revised slightly higher</p>\n<p>* Tesla jumps as CEO Musk says he has sold 'enough' stock</p>\n<p>* Pfizer rises as oral COVID-19 pill wins approval</p>\n<p>* Indexes up: Dow 0.74%, S&amp;P 1.02%, Nasdaq 1.18% </p>\n<p>Dec 22 (Reuters) - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.</p>\n<p>The S&amp;P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of Omicron and an otherwise strong year for equities.</p>\n<p>A South African study suggested reduced risks of hospitalization and severe disease in people infected with the Omicron variant versus the Delta one, but World Health Organization officials cautioned that it was too soon to draw firm conclusions.</p>\n<p>“We are still struggling for direction in the face of the Omicron outbreak, but in the past few days ... more and more evidence is building that the strain is potentially less severe than prior strains, specifically Delta, which bodes well for economic momentum in 2022,” said Mike Stritch, chief investment officer at BMO Wealth Management.</p>\n<p>The Dow Jones Industrial Average rose 261.19 points, or 0.74%, to 35,753.89, the S&amp;P 500 gained 47.33 points, or 1.02%, to 4,696.56 and the Nasdaq Composite added 180.81 points, or 1.18%, to 15,521.89.</p>\n<p>All major S&amp;P 500 sectors gained, with the consumer discretionary group up 1.7% and technology up 1.3%.</p>\n<p>Tesla Inc shares rose 7.5%, boosting the S&amp;P 500 and Nasdaq. Tesla Chief Executive Elon Musk said in an interview he has sold \"enough stock\" following several weeks of share sales by the billionaire.</p>\n<p>U.S. consumer confidence improved further in December, suggesting the economy would continue to expand in 2022. The survey from the Conference Board showed more consumers planned to buy a house and big-ticket items such as motor vehicles and major household appliances as well as go on vacation over the next six months.</p>\n<p>Other reports showed U.S. home sales increased for a third straight month in November, and that gross domestic product increased at a 2.3% annualized rate in the July-September quarter, revised up from the 2.1% rate estimated last month.</p>\n<p>In another encouraging development against the pandemic, the United States authorized Pfizer Inc's oral antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first at-home treatment for the coronavirus. Pfizer shares rose 1%.</p>\n<p>The benchmark S&amp;P 500 is now up 25% so far in 2021. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022 to rein in inflation.</p>\n<p>The market is \"certainly at an extended level of valuation,\" said Rick Meckler, partner at Cherry Lane Investments in New Vernon, New Jersey. “Next year is a more difficult picture, but if inflation is going to be part of the problem, I think investors will certainly choose stocks over bonds.”</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 3.17-to-1 ratio; on Nasdaq, a 1.65-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and no new lows; the Nasdaq Composite recorded 35 new highs and 99 new lows.</p>\n<p>About 8.6 billion shares changed hands in U.S. exchanges, below the 11.8 billion daily average over the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St mints strong gains on rosy economic data, encouraging Omicron update</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St mints strong gains on rosy economic data, encouraging Omicron update\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-23 06:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Consumer confidence index increases in December</p>\n<p>* U.S. Q3 economic growth revised slightly higher</p>\n<p>* Tesla jumps as CEO Musk says he has sold 'enough' stock</p>\n<p>* Pfizer rises as oral COVID-19 pill wins approval</p>\n<p>* Indexes up: Dow 0.74%, S&amp;P 1.02%, Nasdaq 1.18% </p>\n<p>Dec 22 (Reuters) - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.</p>\n<p>The S&amp;P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of Omicron and an otherwise strong year for equities.</p>\n<p>A South African study suggested reduced risks of hospitalization and severe disease in people infected with the Omicron variant versus the Delta one, but World Health Organization officials cautioned that it was too soon to draw firm conclusions.</p>\n<p>“We are still struggling for direction in the face of the Omicron outbreak, but in the past few days ... more and more evidence is building that the strain is potentially less severe than prior strains, specifically Delta, which bodes well for economic momentum in 2022,” said Mike Stritch, chief investment officer at BMO Wealth Management.</p>\n<p>The Dow Jones Industrial Average rose 261.19 points, or 0.74%, to 35,753.89, the S&amp;P 500 gained 47.33 points, or 1.02%, to 4,696.56 and the Nasdaq Composite added 180.81 points, or 1.18%, to 15,521.89.</p>\n<p>All major S&amp;P 500 sectors gained, with the consumer discretionary group up 1.7% and technology up 1.3%.</p>\n<p>Tesla Inc shares rose 7.5%, boosting the S&amp;P 500 and Nasdaq. Tesla Chief Executive Elon Musk said in an interview he has sold \"enough stock\" following several weeks of share sales by the billionaire.</p>\n<p>U.S. consumer confidence improved further in December, suggesting the economy would continue to expand in 2022. The survey from the Conference Board showed more consumers planned to buy a house and big-ticket items such as motor vehicles and major household appliances as well as go on vacation over the next six months.</p>\n<p>Other reports showed U.S. home sales increased for a third straight month in November, and that gross domestic product increased at a 2.3% annualized rate in the July-September quarter, revised up from the 2.1% rate estimated last month.</p>\n<p>In another encouraging development against the pandemic, the United States authorized Pfizer Inc's oral antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first at-home treatment for the coronavirus. Pfizer shares rose 1%.</p>\n<p>The benchmark S&amp;P 500 is now up 25% so far in 2021. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022 to rein in inflation.</p>\n<p>The market is \"certainly at an extended level of valuation,\" said Rick Meckler, partner at Cherry Lane Investments in New Vernon, New Jersey. “Next year is a more difficult picture, but if inflation is going to be part of the problem, I think investors will certainly choose stocks over bonds.”</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 3.17-to-1 ratio; on Nasdaq, a 1.65-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and no new lows; the Nasdaq Composite recorded 35 new highs and 99 new lows.</p>\n<p>About 8.6 billion shares changed hands in U.S. exchanges, below the 11.8 billion daily average over the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4007":"制药","BK4568":"美国抗疫概念",".IXIC":"NASDAQ Composite","PFE":"辉瑞",".DJI":"道琼斯","BK4533":"AQR资本管理(全球第二大对冲基金)","COMP":"Compass, Inc.","TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193113147","content_text":"* Consumer confidence index increases in December\n* U.S. Q3 economic growth revised slightly higher\n* Tesla jumps as CEO Musk says he has sold 'enough' stock\n* Pfizer rises as oral COVID-19 pill wins approval\n* Indexes up: Dow 0.74%, S&P 1.02%, Nasdaq 1.18% \nDec 22 (Reuters) - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.\nThe S&P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of Omicron and an otherwise strong year for equities.\nA South African study suggested reduced risks of hospitalization and severe disease in people infected with the Omicron variant versus the Delta one, but World Health Organization officials cautioned that it was too soon to draw firm conclusions.\n“We are still struggling for direction in the face of the Omicron outbreak, but in the past few days ... more and more evidence is building that the strain is potentially less severe than prior strains, specifically Delta, which bodes well for economic momentum in 2022,” said Mike Stritch, chief investment officer at BMO Wealth Management.\nThe Dow Jones Industrial Average rose 261.19 points, or 0.74%, to 35,753.89, the S&P 500 gained 47.33 points, or 1.02%, to 4,696.56 and the Nasdaq Composite added 180.81 points, or 1.18%, to 15,521.89.\nAll major S&P 500 sectors gained, with the consumer discretionary group up 1.7% and technology up 1.3%.\nTesla Inc shares rose 7.5%, boosting the S&P 500 and Nasdaq. Tesla Chief Executive Elon Musk said in an interview he has sold \"enough stock\" following several weeks of share sales by the billionaire.\nU.S. consumer confidence improved further in December, suggesting the economy would continue to expand in 2022. The survey from the Conference Board showed more consumers planned to buy a house and big-ticket items such as motor vehicles and major household appliances as well as go on vacation over the next six months.\nOther reports showed U.S. home sales increased for a third straight month in November, and that gross domestic product increased at a 2.3% annualized rate in the July-September quarter, revised up from the 2.1% rate estimated last month.\nIn another encouraging development against the pandemic, the United States authorized Pfizer Inc's oral antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first at-home treatment for the coronavirus. Pfizer shares rose 1%.\nThe benchmark S&P 500 is now up 25% so far in 2021. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022 to rein in inflation.\nThe market is \"certainly at an extended level of valuation,\" said Rick Meckler, partner at Cherry Lane Investments in New Vernon, New Jersey. “Next year is a more difficult picture, but if inflation is going to be part of the problem, I think investors will certainly choose stocks over bonds.”\nAdvancing issues outnumbered declining ones on the NYSE by a 3.17-to-1 ratio; on Nasdaq, a 1.65-to-1 ratio favored advancers.\nThe S&P 500 posted 15 new 52-week highs and no new lows; the Nasdaq Composite recorded 35 new highs and 99 new lows.\nAbout 8.6 billion shares changed hands in U.S. exchanges, below the 11.8 billion daily average over the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":495,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9094490109,"gmtCreate":1645198091712,"gmtModify":1676534008360,"author":{"id":"4088495159199840","authorId":"4088495159199840","name":"zbhtet","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088495159199840","authorIdStr":"4088495159199840"},"themes":[],"htmlText":"Pls like&nbsp;","listText":"Pls like&nbsp;","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9094490109","repostId":"1197876155","repostType":2,"repost":{"id":"1197876155","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1645197621,"share":"https://ttm.financial/m/news/1197876155?lang=&edition=fundamental","pubTime":"2022-02-18 23:20","market":"us","language":"en","title":"Blue Water Vaccines Surged 364.44% in Its First Day of Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1197876155","media":"Tiger Newspress","summary":"Blue Water Vaccines surged 364.44% in its first day of trading.Blue Water Vaccines, Inc. , a biophar","content":"<html><head></head><body><p>Blue Water Vaccines surged 364.44% in its first day of trading.</p><p><img src=\"https://static.tigerbbs.com/702d2200844a133c27a77cab92a7fff0\" tg-width=\"1243\" tg-height=\"659\" width=\"100%\" height=\"auto\"/>Blue Water Vaccines, Inc. , a biopharmaceutical company developing vaccines, announced the pricing of its initial public offering of 2,222,222 shares of its common stock at a public offering price of $9.00 per share. The shares begin trading on the Nasdaq Capital Market under the ticker symbol &#34;BWV&#34; on Friday.</p><p>Blue Water Vaccines, Inc. is a biopharmaceutical company focused on developing transformational vaccines to address significant health challenges globally. Headquartered in Cincinnati, OH, the company holds the rights to proprietary technology developed at the University of Oxford, Cincinnati Children&#39;s Hospital Medical Center (CCHMC), and St. Jude Children&#39;s Hospital. </p><p>The company is developing a universal flu vaccine that will provide protection from all virulent strains and a <i>Streptococcus pneumoniae</i> (pneumococcus) vaccine candidate, designed to specifically prevent the highly infectious middle ear infections, known as Acute Otitis Media (AOM), in children. Additionally, Blue Water Vaccines has licensed a novel norovirus (NoV) S&amp;P nanoparticle versatile virus-like particle (VLP) vaccine platform from CCHMC to develop vaccines for multiple infectious diseases, including norovirus/rotavirus and malaria among others.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Blue Water Vaccines Surged 364.44% in Its First Day of Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBlue Water Vaccines Surged 364.44% in Its First Day of Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-02-18 23:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Blue Water Vaccines surged 364.44% in its first day of trading.</p><p><img src=\"https://static.tigerbbs.com/702d2200844a133c27a77cab92a7fff0\" tg-width=\"1243\" tg-height=\"659\" width=\"100%\" height=\"auto\"/>Blue Water Vaccines, Inc. , a biopharmaceutical company developing vaccines, announced the pricing of its initial public offering of 2,222,222 shares of its common stock at a public offering price of $9.00 per share. The shares begin trading on the Nasdaq Capital Market under the ticker symbol &#34;BWV&#34; on Friday.</p><p>Blue Water Vaccines, Inc. is a biopharmaceutical company focused on developing transformational vaccines to address significant health challenges globally. Headquartered in Cincinnati, OH, the company holds the rights to proprietary technology developed at the University of Oxford, Cincinnati Children&#39;s Hospital Medical Center (CCHMC), and St. Jude Children&#39;s Hospital. </p><p>The company is developing a universal flu vaccine that will provide protection from all virulent strains and a <i>Streptococcus pneumoniae</i> (pneumococcus) vaccine candidate, designed to specifically prevent the highly infectious middle ear infections, known as Acute Otitis Media (AOM), in children. Additionally, Blue Water Vaccines has licensed a novel norovirus (NoV) S&amp;P nanoparticle versatile virus-like particle (VLP) vaccine platform from CCHMC to develop vaccines for multiple infectious diseases, including norovirus/rotavirus and malaria among others.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197876155","content_text":"Blue Water Vaccines surged 364.44% in its first day of trading.Blue Water Vaccines, Inc. , a biopharmaceutical company developing vaccines, announced the pricing of its initial public offering of 2,222,222 shares of its common stock at a public offering price of $9.00 per share. The shares begin trading on the Nasdaq Capital Market under the ticker symbol \"BWV\" on Friday.Blue Water Vaccines, Inc. is a biopharmaceutical company focused on developing transformational vaccines to address significant health challenges globally. Headquartered in Cincinnati, OH, the company holds the rights to proprietary technology developed at the University of Oxford, Cincinnati Children's Hospital Medical Center (CCHMC), and St. Jude Children's Hospital. The company is developing a universal flu vaccine that will provide protection from all virulent strains and a Streptococcus pneumoniae (pneumococcus) vaccine candidate, designed to specifically prevent the highly infectious middle ear infections, known as Acute Otitis Media (AOM), in children. Additionally, Blue Water Vaccines has licensed a novel norovirus (NoV) S&P nanoparticle versatile virus-like particle (VLP) vaccine platform from CCHMC to develop vaccines for multiple infectious diseases, including norovirus/rotavirus and malaria among others.","news_type":1},"isVote":1,"tweetType":1,"viewCount":685,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9030459042,"gmtCreate":1645794189931,"gmtModify":1676534064849,"author":{"id":"4088495159199840","authorId":"4088495159199840","name":"zbhtet","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088495159199840","authorIdStr":"4088495159199840"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9030459042","repostId":"1185987372","repostType":2,"repost":{"id":"1185987372","kind":"news","pubTimestamp":1645783612,"share":"https://ttm.financial/m/news/1185987372?lang=&edition=fundamental","pubTime":"2022-02-25 18:06","market":"us","language":"en","title":"U.S. Stocks Poised to Fall as Russia Continues Ukraine Onslaught","url":"https://stock-news.laohu8.com/highlight/detail?id=1185987372","media":"The Wall Street Journal","summary":"Stock futures decline, while Russian shares jump and oil prices edge higherU.S. stocks were poised f","content":"<html><head></head><body><p>Stock futures decline, while Russian shares jump and oil prices edge higher</p><p><img src=\"https://static.tigerbbs.com/1e9ee2e50f421d60d5ee0a2e060e8607\" tg-width=\"1184\" tg-height=\"692\" width=\"100%\" height=\"auto\"/></p><p>U.S. stocks were poised for further volatility, as investors sought to make sense of the potentially far-reaching implications of war in Ukraine for individual companies and the wider economy.</p><p>Futures for the S&amp;P 500 fell 1.2% Friday, a day after the benchmark index capped a wild trading session by closing 1.5% higher, as investors piled into growth and technology stocks. Futures for the Dow Jones Industrial Average fell 1% and those for the technology-focused Nasdaq-100 lost 1.4% Friday.</p><p>Overseas, markets regained some poise after sanctions laid out by President Bidenstopped short of some of the most severe measures investors had thought might be on the table. Russia’s Moex stock-market gauge, which endured a historic blow Thursday, rose 12.9%.</p><p>The Stoxx Europe 600 rose 0.7%, led by shares of resource and travel companies. Japan’s Nikkei 225 rose 2%, and the CSI 300, which comprises the largest stocks listed in Shanghai and Shenzhen, rose 1%, after both fell Thursday. Hong Kong’s Hang Seng Index slipped 0.6%.</p><p>In energy markets, futures for Brent crude, the global oil benchmark, rose 1.5% to $96.81 a barrel, while European natural-gas prices retreated by almost a quarter after rocketing Thursday.Brent topped $100 a barrel early Thursday before falling back.</p><p>Russian forces renewed bombing Ukraine early Friday, with central Kyiv rocked by explosions. Investors are pondering how the fighting, its effect on commodity markets and retaliatory Western sanctions will ripple through a world economy already grappling with elevated inflation and coming interest-rate rises by major central banks.</p><p>The U.S. and its allies have laid out stiff restrictions on Russian companies and their ability to interact with the international financial system. The European Union will formally sign off on sanctions Friday that willc ut 70% of Russia’s banking system off from international financial markets. Officials in Ukraine, the Baltics and the U.K. are calling for the sanctions to go further, cutting Russia off completely from infrastructure that ties together banks around the world.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b508620b24a78a56758f2e1dd2935e59\" tg-width=\"1050\" tg-height=\"699\" width=\"100%\" height=\"auto\"/><span>Investors are pondering how sanctions will affect the global economy.</span></p><p>“I do not think that this highly volatile period is already coming to an end,” said Daniel Egger, chief investment officer at St. Gotthard Fund Management. “Right now we have to focus now on what’s happening in Kyiv, how bloody the coming days will be, and I would say definitely the Russian sanctions still can be stepped up.”</p><p>In bond markets, yields fell in a sign investors still sought the safety of safe-haven assets. The yield on the benchmark U.S. 10-year Treasury note declined to 1.949% from 1.969% Thursday. Yields and prices move inversely. Gold prices, however, slipped 0.7% to $1,914 a troy ounce.</p><p>Among individual European stocks, some companies that were hammered at the start of Russia’s attack clawed back some lost ground. Russian gold producer Polymetal International rose 14%. Hungarian budget airline Wizz Air rose 4.9%. But banks with exposure to Russia or commodity markets came under pressure, including ING Groep,Société Générale and UniCredit. Shares of British arms and aerospace company BAE Systems, which has gained on the prospect of higher defense spending, added a further 4.3%.</p><p>“It looks like the military action in Ukraine could be protracted,” said Yung-Yu Ma, chief investment strategist for BMO Wealth Management in the U.S. In this case, short-term market movement is difficult to predict, he said.</p><p>Rapid inflation and the prospect of tighter monetary policy were complicating the outlook for some traditional safe-haven assets such as Treasury bonds, the U.S. dollar and gold, Mr. Ma added.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. Stocks Poised to Fall as Russia Continues Ukraine Onslaught</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. Stocks Poised to Fall as Russia Continues Ukraine Onslaught\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-25 18:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/global-stocks-markets-dow-update-02-25-22-11645771218?page=1><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stock futures decline, while Russian shares jump and oil prices edge higherU.S. stocks were poised for further volatility, as investors sought to make sense of the potentially far-reaching ...</p>\n\n<a href=\"https://www.wsj.com/articles/global-stocks-markets-dow-update-02-25-22-11645771218?page=1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://www.wsj.com/articles/global-stocks-markets-dow-update-02-25-22-11645771218?page=1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185987372","content_text":"Stock futures decline, while Russian shares jump and oil prices edge higherU.S. stocks were poised for further volatility, as investors sought to make sense of the potentially far-reaching implications of war in Ukraine for individual companies and the wider economy.Futures for the S&P 500 fell 1.2% Friday, a day after the benchmark index capped a wild trading session by closing 1.5% higher, as investors piled into growth and technology stocks. Futures for the Dow Jones Industrial Average fell 1% and those for the technology-focused Nasdaq-100 lost 1.4% Friday.Overseas, markets regained some poise after sanctions laid out by President Bidenstopped short of some of the most severe measures investors had thought might be on the table. Russia’s Moex stock-market gauge, which endured a historic blow Thursday, rose 12.9%.The Stoxx Europe 600 rose 0.7%, led by shares of resource and travel companies. Japan’s Nikkei 225 rose 2%, and the CSI 300, which comprises the largest stocks listed in Shanghai and Shenzhen, rose 1%, after both fell Thursday. Hong Kong’s Hang Seng Index slipped 0.6%.In energy markets, futures for Brent crude, the global oil benchmark, rose 1.5% to $96.81 a barrel, while European natural-gas prices retreated by almost a quarter after rocketing Thursday.Brent topped $100 a barrel early Thursday before falling back.Russian forces renewed bombing Ukraine early Friday, with central Kyiv rocked by explosions. Investors are pondering how the fighting, its effect on commodity markets and retaliatory Western sanctions will ripple through a world economy already grappling with elevated inflation and coming interest-rate rises by major central banks.The U.S. and its allies have laid out stiff restrictions on Russian companies and their ability to interact with the international financial system. The European Union will formally sign off on sanctions Friday that willc ut 70% of Russia’s banking system off from international financial markets. Officials in Ukraine, the Baltics and the U.K. are calling for the sanctions to go further, cutting Russia off completely from infrastructure that ties together banks around the world.Investors are pondering how sanctions will affect the global economy.“I do not think that this highly volatile period is already coming to an end,” said Daniel Egger, chief investment officer at St. Gotthard Fund Management. “Right now we have to focus now on what’s happening in Kyiv, how bloody the coming days will be, and I would say definitely the Russian sanctions still can be stepped up.”In bond markets, yields fell in a sign investors still sought the safety of safe-haven assets. The yield on the benchmark U.S. 10-year Treasury note declined to 1.949% from 1.969% Thursday. Yields and prices move inversely. Gold prices, however, slipped 0.7% to $1,914 a troy ounce.Among individual European stocks, some companies that were hammered at the start of Russia’s attack clawed back some lost ground. Russian gold producer Polymetal International rose 14%. Hungarian budget airline Wizz Air rose 4.9%. But banks with exposure to Russia or commodity markets came under pressure, including ING Groep,Société Générale and UniCredit. Shares of British arms and aerospace company BAE Systems, which has gained on the prospect of higher defense spending, added a further 4.3%.“It looks like the military action in Ukraine could be protracted,” said Yung-Yu Ma, chief investment strategist for BMO Wealth Management in the U.S. In this case, short-term market movement is difficult to predict, he said.Rapid inflation and the prospect of tighter monetary policy were complicating the outlook for some traditional safe-haven assets such as Treasury bonds, the U.S. dollar and gold, Mr. Ma added.","news_type":1},"isVote":1,"tweetType":1,"viewCount":642,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9093254942,"gmtCreate":1643644785529,"gmtModify":1676533839745,"author":{"id":"4088495159199840","authorId":"4088495159199840","name":"zbhtet","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088495159199840","authorIdStr":"4088495159199840"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9093254942","repostId":"1173569070","repostType":4,"repost":{"id":"1173569070","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1643641805,"share":"https://ttm.financial/m/news/1173569070?lang=&edition=fundamental","pubTime":"2022-01-31 23:10","market":"us","language":"en","title":"Boeing shares rose more than 2% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1173569070","media":"Tiger Newspress","summary":"Boeing shares rose more than 2% in morning trading.Boeing Co    is set to sign a launch order from Q","content":"<html><head></head><body><p>Boeing shares rose more than 2% in morning trading.<img src=\"https://static.tigerbbs.com/8b4bcff3932492fe06a1494202fb6d1e\" tg-width=\"702\" tg-height=\"594\" width=\"100%\" height=\"auto\"/>Boeing Co    is set to sign a launch order from Qatar Airways for a new freighter version of its 777X passenger jet on Monday, in a Washington ceremony coinciding with a visit by the Gulf state&#39;s ruling emir, U.S. officials said.</p><p>Reuters reported last week that the U.S. planemaker was in advanced negotiations with the Gulf carrier for around 34 of the planned twin-engined freighters in a deal provisionally estimated to be worth $14 billion at list prices.</p><p>Qatar Airways has publicly said it is interested in buying up to 50 new-generation freighters, with the higher figure expected to include options that could lead to top-up purchases in the future.</p><p>It may also bridge to the new cargo version of the upgraded 777X with a handful of extra current-generation 777 freighters.</p><p>The deal, which could effectively kickstart development of the new freighter, is expected to be signed at a White House ceremony at 12:30 pm local (1630 GMT), the officials said.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Boeing shares rose more than 2% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBoeing shares rose more than 2% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-31 23:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Boeing shares rose more than 2% in morning trading.<img src=\"https://static.tigerbbs.com/8b4bcff3932492fe06a1494202fb6d1e\" tg-width=\"702\" tg-height=\"594\" width=\"100%\" height=\"auto\"/>Boeing Co    is set to sign a launch order from Qatar Airways for a new freighter version of its 777X passenger jet on Monday, in a Washington ceremony coinciding with a visit by the Gulf state&#39;s ruling emir, U.S. officials said.</p><p>Reuters reported last week that the U.S. planemaker was in advanced negotiations with the Gulf carrier for around 34 of the planned twin-engined freighters in a deal provisionally estimated to be worth $14 billion at list prices.</p><p>Qatar Airways has publicly said it is interested in buying up to 50 new-generation freighters, with the higher figure expected to include options that could lead to top-up purchases in the future.</p><p>It may also bridge to the new cargo version of the upgraded 777X with a handful of extra current-generation 777 freighters.</p><p>The deal, which could effectively kickstart development of the new freighter, is expected to be signed at a White House ceremony at 12:30 pm local (1630 GMT), the officials said.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BA":"波音"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173569070","content_text":"Boeing shares rose more than 2% in morning trading.Boeing Co    is set to sign a launch order from Qatar Airways for a new freighter version of its 777X passenger jet on Monday, in a Washington ceremony coinciding with a visit by the Gulf state's ruling emir, U.S. officials said.Reuters reported last week that the U.S. planemaker was in advanced negotiations with the Gulf carrier for around 34 of the planned twin-engined freighters in a deal provisionally estimated to be worth $14 billion at list prices.Qatar Airways has publicly said it is interested in buying up to 50 new-generation freighters, with the higher figure expected to include options that could lead to top-up purchases in the future.It may also bridge to the new cargo version of the upgraded 777X with a handful of extra current-generation 777 freighters.The deal, which could effectively kickstart development of the new freighter, is expected to be signed at a White House ceremony at 12:30 pm local (1630 GMT), the officials said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":647,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9098751610,"gmtCreate":1644241283547,"gmtModify":1676533903082,"author":{"id":"4088495159199840","authorId":"4088495159199840","name":"zbhtet","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088495159199840","authorIdStr":"4088495159199840"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9098751610","repostId":"2209320195","repostType":2,"repost":{"id":"2209320195","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1644226500,"share":"https://ttm.financial/m/news/2209320195?lang=&edition=fundamental","pubTime":"2022-02-07 17:35","market":"us","language":"en","title":"5 Stocks To Watch For February 7, 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2209320195","media":"Benzinga","summary":"Some of the stocks that may grab inve3stor focus today are:\n\tWall Street expects  Tyson Foods, Inc. (NYSE: TSN) to report quarterly earnings at $1.90 per share on revenue of $12.18 billion after the closing bell. Tyson Foods shares rose 1.1% to $89.25 in pre-market trading.\n","content":"<html><head></head><body><p>Some of the stocks that may grab investor focus today are:</p><ul><li>Wall Street expects <b> Tyson Foods, Inc.</b> (NYSE:TSN) to report quarterly earnings at $1.90 per share on revenue of $12.18 billion after the closing bell. Tyson Foods shares rose 1.1% to $89.25 in pre-market trading.</li><li><b>Century Aluminum Company</b> (NASDAQ:CENX) said Craig Conti will be leaving the company. Michelle Harrison, the Company’s Senior Vice President, Finance and Treasurer will assume responsibilities during the company’s search for replacement.</li><li>Analysts are expecting <b> Zimmer Biomet Holdings, Inc. </b> (NYSE:ZBH) to have earned $1.98 per share on revenue of $2.07 billion for the latest quarter. The company will release earnings before the markets open. Zimmer Biomet shares gained 0.1% to $123.00 in pre-market trading.</li></ul><ul><li>Analysts expect <b> Amgen Inc.</b> (NASDAQ:AMGN) to report quarterly earnings at $4.12 per share on revenue of $6.88 billion after the closing bell. Amgen shares fell 0.2% to $221.57 in after-hours trading.</li><li>Before the opening bell, <b> Hasbro, Inc.</b> (NASDAQ:HAS) is projected to report quarterly earnings at $0.88 per share on revenue of $1.87 billion. Hasbro shares fell 0.1% to $93.90 in after-hours trading.</li></ul></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For February 7, 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For February 7, 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2022-02-07 17:35</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Some of the stocks that may grab investor focus today are:</p><ul><li>Wall Street expects <b> Tyson Foods, Inc.</b> (NYSE:TSN) to report quarterly earnings at $1.90 per share on revenue of $12.18 billion after the closing bell. Tyson Foods shares rose 1.1% to $89.25 in pre-market trading.</li><li><b>Century Aluminum Company</b> (NASDAQ:CENX) said Craig Conti will be leaving the company. Michelle Harrison, the Company’s Senior Vice President, Finance and Treasurer will assume responsibilities during the company’s search for replacement.</li><li>Analysts are expecting <b> Zimmer Biomet Holdings, Inc. </b> (NYSE:ZBH) to have earned $1.98 per share on revenue of $2.07 billion for the latest quarter. The company will release earnings before the markets open. Zimmer Biomet shares gained 0.1% to $123.00 in pre-market trading.</li></ul><ul><li>Analysts expect <b> Amgen Inc.</b> (NASDAQ:AMGN) to report quarterly earnings at $4.12 per share on revenue of $6.88 billion after the closing bell. Amgen shares fell 0.2% to $221.57 in after-hours trading.</li><li>Before the opening bell, <b> Hasbro, Inc.</b> (NASDAQ:HAS) is projected to report quarterly earnings at $0.88 per share on revenue of $1.87 billion. Hasbro shares fell 0.1% to $93.90 in after-hours trading.</li></ul></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMGN":"安进","BK4527":"明星科技股","BK4525":"远程办公概念","HAS":"孩之宝","BK4153":"铝","CENX":"世纪铝业","BK4548":"巴美列捷福持仓","BK4514":"搜索引擎","BK4553":"喜马拉雅资本持仓","GOOG":"谷歌","BK4082":"医疗保健设备","TSN":"泰森食品","ZBH":"齐默巴奥米特控股","BK4139":"生物科技"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2209320195","content_text":"Some of the stocks that may grab investor focus today are:Wall Street expects  Tyson Foods, Inc. (NYSE:TSN) to report quarterly earnings at $1.90 per share on revenue of $12.18 billion after the closing bell. Tyson Foods shares rose 1.1% to $89.25 in pre-market trading.Century Aluminum Company (NASDAQ:CENX) said Craig Conti will be leaving the company. Michelle Harrison, the Company’s Senior Vice President, Finance and Treasurer will assume responsibilities during the company’s search for replacement.Analysts are expecting  Zimmer Biomet Holdings, Inc.  (NYSE:ZBH) to have earned $1.98 per share on revenue of $2.07 billion for the latest quarter. The company will release earnings before the markets open. Zimmer Biomet shares gained 0.1% to $123.00 in pre-market trading.Analysts expect  Amgen Inc. (NASDAQ:AMGN) to report quarterly earnings at $4.12 per share on revenue of $6.88 billion after the closing bell. Amgen shares fell 0.2% to $221.57 in after-hours trading.Before the opening bell,  Hasbro, Inc. (NASDAQ:HAS) is projected to report quarterly earnings at $0.88 per share on revenue of $1.87 billion. Hasbro shares fell 0.1% to $93.90 in after-hours trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":936,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9093704382,"gmtCreate":1643699447551,"gmtModify":1676533846050,"author":{"id":"4088495159199840","authorId":"4088495159199840","name":"zbhtet","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088495159199840","authorIdStr":"4088495159199840"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9093704382","repostId":"1197842729","repostType":4,"repost":{"id":"1197842729","kind":"news","pubTimestamp":1643674410,"share":"https://ttm.financial/m/news/1197842729?lang=&edition=fundamental","pubTime":"2022-02-01 08:13","market":"us","language":"en","title":"Is Palantir's Stock Too Cheap? Guy Adami Thinks So","url":"https://stock-news.laohu8.com/highlight/detail?id=1197842729","media":"Benzinga","summary":"Palantir Technologies Inc is down more than 60% over the past year and nearly 25% this month alone. ","content":"<html><head></head><body><p>Palantir Technologies Inc is down more than 60% over the past year and nearly 25% this month alone. That&#39;s a pretty downbeat start to 2022 for the data analytics company, but Private Advisor Group&#39;s Guy Adami thinks patient investors will be rewarded.</p><p>&#34;Data is the new oil,&#34; Adami said Monday on CNBC&#39;s &#34;Fast Money.&#34;</p><p>&#34;They&#39;re in the midst of it ... and I just don&#39;t think people fully understand.&#34;</p><p>He noted the stock was off to a great start in 2021 but ended up getting caught up in the WallStreetBets frenzy. Members of the popular subreddit banded together and sent stocks such as GameStop Corp. and AMC Entertainment Holdings Inc soaring.</p><p>Adami thinks Palantir&#39;s involvement was detrimental for the stock longer-term, which seems clear when looking at its performance over the past year.</p><p>He expects the company to expand its offerings for medium-sized businesses, which will ultimately improve margins.</p><p>&#34;I think this stock with a 13 handle is just too cheap in this environment,&#34; Adami said.</p><p>From Last Week: This Is What Whales Are Betting On Palantir Technologies</p><p>PLTR Price Action: Palantir has traded as low as $11.75 and as high as $39.22 over a 52-week period.</p><p>The stock was up 1.09% in after-hours trading at $13.86 Monday at publication.</p></body></html>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Palantir's Stock Too Cheap? Guy Adami Thinks So</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Palantir's Stock Too Cheap? Guy Adami Thinks So\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-01 08:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/trading-ideas/long-ideas/22/01/25326401/is-palantirs-stock-too-cheap-guy-adami-thinks-so><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Palantir Technologies Inc is down more than 60% over the past year and nearly 25% this month alone. That's a pretty downbeat start to 2022 for the data analytics company, but Private Advisor Group's ...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/long-ideas/22/01/25326401/is-palantirs-stock-too-cheap-guy-adami-thinks-so\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://www.benzinga.com/trading-ideas/long-ideas/22/01/25326401/is-palantirs-stock-too-cheap-guy-adami-thinks-so","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197842729","content_text":"Palantir Technologies Inc is down more than 60% over the past year and nearly 25% this month alone. That's a pretty downbeat start to 2022 for the data analytics company, but Private Advisor Group's Guy Adami thinks patient investors will be rewarded.\"Data is the new oil,\" Adami said Monday on CNBC's \"Fast Money.\"\"They're in the midst of it ... and I just don't think people fully understand.\"He noted the stock was off to a great start in 2021 but ended up getting caught up in the WallStreetBets frenzy. Members of the popular subreddit banded together and sent stocks such as GameStop Corp. and AMC Entertainment Holdings Inc soaring.Adami thinks Palantir's involvement was detrimental for the stock longer-term, which seems clear when looking at its performance over the past year.He expects the company to expand its offerings for medium-sized businesses, which will ultimately improve margins.\"I think this stock with a 13 handle is just too cheap in this environment,\" Adami said.From Last Week: This Is What Whales Are Betting On Palantir TechnologiesPLTR Price Action: Palantir has traded as low as $11.75 and as high as $39.22 over a 52-week period.The stock was up 1.09% in after-hours trading at $13.86 Monday at publication.","news_type":1},"isVote":1,"tweetType":1,"viewCount":301,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9093705452,"gmtCreate":1643699404873,"gmtModify":1676533846051,"author":{"id":"4088495159199840","authorId":"4088495159199840","name":"zbhtet","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088495159199840","authorIdStr":"4088495159199840"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9093705452","repostId":"2207226382","repostType":4,"repost":{"id":"2207226382","kind":"highlight","pubTimestamp":1643674838,"share":"https://ttm.financial/m/news/2207226382?lang=&edition=fundamental","pubTime":"2022-02-01 08:20","market":"us","language":"en","title":"Are Warren Buffett's 3 Cheapest Stocks Screaming Buys?","url":"https://stock-news.laohu8.com/highlight/detail?id=2207226382","media":"Motley Fool","summary":"Bristol Myers Squibb, General Motors, and Teva Pharmaceutical Industries are three dirt cheap Buffett stocks worth buying right now.","content":"<html><head></head><body><p><b>Berkshire Hathaway</b> CEO and world-renowned superinvestor Warren Buffett is a dyed-in-the-wool value investor. Buffett&#39;s core strategy centers around buying shares of companies with remarkably strong underlying businesses (deep competitive moats, global brand recognition, reliable and growing free cash flows, etc.), yet whose shares trade at a discount relative to their intrinsic value.</p><p>And this value-oriented approach has certainly served Buffett well during his tenure as Berkshire CEO. Since taking the reins of the diversified holding company 56-plus years ago, Berkshire&#39;s stock has delivered total returns on capital in excess of 6,450%. In fact, $10,000 invested in Berkshire stock at the time Buffett become CEO would be worth approximately $654,890 today.</p><p><img src=\"https://static.tigerbbs.com/6d9a90b9030efaa614666da83153f552\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><p>Image source: Getty Images.</p><p>Berkshire&#39;s various holdings aren&#39;t all top value stocks, however. The reality of the situation is that Berkshire, along with most other mega-funds, often gets special incentives, such as an elevated dividend yield, to buy shares of a company in bulk.</p><p>As a result, the value proposition offered to large holding firms like Berkshire is often drastically different than the <a href=\"https://laohu8.com/S/AONE.U\">one</a> available to ordinary retail investors via a company&#39;s common stock. Retail investors, in turn, shouldn&#39;t necessarily buy shares of a Buffett stock simply because it looks cheap based on a classic valuation metric such as price to earnings, price to book, or price to sales.</p><p>Armed with this insight, let&#39;s break down whether Berkshire&#39;s three cheapest holdings, based on their forward-looking price-to-earnings ratios, are bona fide value stocks suitable for retail investors.</p><h2>A top big pharma stock</h2><p>At a hair under eight times forward earnings, the pharmaceutical giant <b>Bristol Myers Squibb</b> (NYSE:BMY) is Berkshire&#39;s third-cheapest stock holding at the moment. Bristol&#39;s shares have essentially treaded water over the past year due to its three top-selling medications (Eliquis, Opdivo, and Revlimid) losing market exclusivity this decade.</p><p>While this wave of patent expirations may be worrisome at first glance, the drugmaker does have a solid plan in place to not only offset these future sales declines, but to keep its top line humming along all the way out to 2030. Namely, Bristol has multiple new drug launches planned over the next few years, several of which are for potential blockbuster medications.</p><p>The long and short of it is that this isn&#39;t Bristol&#39;s first bout with the patent cliff. The company has lost market exclusivity for scores of blockbuster medications in the past. Yet it has always managed to hit on new growth products to create enormous value for long-term shareholders. Value-oriented investors, in turn, shouldn&#39;t hesitate to capitalize on the market&#39;s overreaction to the pharma titan&#39;s ongoing portfolio churn.</p><h2>A potential sleeping giant</h2><p>Shares of the large-cap automaker <b>General Motors</b> (NYSE:GM) are currently trading at 7.43 times forward earnings. That&#39;s good for second place on Berkshire&#39;s list of cheapest stock holdings. The auto giant&#39;s stock has stagnated over the last year in response to the rise of electric vehicles, the market-wide disinterest in classic value stocks, and the upcoming interest rate hikes by the Federal Reserve that will surely make monthly payments more expensive for most car buyers.</p><p>General Motors, though, may have some magic in it that the market has yet to fully appreciate. Last summer, the car giant announced an intriguing plan to invest heavily in electric vehicles, autonomous vehicles, and batteries. With a global commercial footprint and rock solid branding power, General Motors could prove to be a formidable competitor in these high-growth segments of the market.</p><p>That said, General Motors&#39; latent value proposition, albeit massive, may take a few years to win over investors. So, while this auto stock does come across as a compelling buy, this Buffett value stock will likely require a multi-year holding period to realize its full potential.</p><h2>Buffett&#39;s cheapest stock holding</h2><p>With its shares trading at 3.12 times forward earnings, Israeli generic and branded drug giant <b>Teva Pharmaceutical Industries</b> (NYSE:TEVA) is Berkshire&#39;s cheapest stock holding by a wide margin.</p><p>The drugmaker&#39;s shares have lost three-quarters of their value over the last five years due to a series of unfortunate events. Specifically, Teva took on far too much debt to acquire Actavis&#39; generic drug portfolio back in 2016, it didn&#39;t have another franchise-level medication waiting in the wings to replace the multiple sclerosis drug Copaxone following its loss of exclusivity, and it has been embroiled in a string of costly lawsuits.</p><p>Teva&#39;s long-awaited turnaround, though, does seem to be coming into focus now, thanks to three key developments. First, the company has slowly built a well-rounded product portfolio that should return it to sustainable levels of growth soon. Second, its various legal problems ought to be resolved in the not-so-distant future. Third, Teva&#39;s ongoing deleveraging process has significantly improved the health of its balance sheet over the past few years. Teva&#39;s stock thus appears poised for a major rebound, perhaps as soon as this year.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Are Warren Buffett's 3 Cheapest Stocks Screaming Buys?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAre Warren Buffett's 3 Cheapest Stocks Screaming Buys?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-01 08:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/31/are-warren-buffetts-3-cheapest-stocks-screaming-bu/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Berkshire Hathaway CEO and world-renowned superinvestor Warren Buffett is a dyed-in-the-wool value investor. Buffett's core strategy centers around buying shares of companies with remarkably strong ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/31/are-warren-buffetts-3-cheapest-stocks-screaming-bu/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4555":"新能源车","BK4099":"汽车制造商","BK4007":"制药","BK4532":"文艺复兴科技持仓","BRK.B":"伯克希尔B","BMY":"施贵宝","BK4566":"资本集团","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4557":"大麻股","BRK.A":"伯克希尔","BK4176":"多领域控股","GM":"通用汽车","BK4534":"瑞士信贷持仓","BK4559":"巴菲特持仓","BK4561":"索罗斯持仓","TEVA":"梯瓦制药","BK4550":"红杉资本持仓"},"source_url":"https://www.fool.com/investing/2022/01/31/are-warren-buffetts-3-cheapest-stocks-screaming-bu/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2207226382","content_text":"Berkshire Hathaway CEO and world-renowned superinvestor Warren Buffett is a dyed-in-the-wool value investor. Buffett's core strategy centers around buying shares of companies with remarkably strong underlying businesses (deep competitive moats, global brand recognition, reliable and growing free cash flows, etc.), yet whose shares trade at a discount relative to their intrinsic value.And this value-oriented approach has certainly served Buffett well during his tenure as Berkshire CEO. Since taking the reins of the diversified holding company 56-plus years ago, Berkshire's stock has delivered total returns on capital in excess of 6,450%. In fact, $10,000 invested in Berkshire stock at the time Buffett become CEO would be worth approximately $654,890 today.Image source: Getty Images.Berkshire's various holdings aren't all top value stocks, however. The reality of the situation is that Berkshire, along with most other mega-funds, often gets special incentives, such as an elevated dividend yield, to buy shares of a company in bulk.As a result, the value proposition offered to large holding firms like Berkshire is often drastically different than the one available to ordinary retail investors via a company's common stock. Retail investors, in turn, shouldn't necessarily buy shares of a Buffett stock simply because it looks cheap based on a classic valuation metric such as price to earnings, price to book, or price to sales.Armed with this insight, let's break down whether Berkshire's three cheapest holdings, based on their forward-looking price-to-earnings ratios, are bona fide value stocks suitable for retail investors.A top big pharma stockAt a hair under eight times forward earnings, the pharmaceutical giant Bristol Myers Squibb (NYSE:BMY) is Berkshire's third-cheapest stock holding at the moment. Bristol's shares have essentially treaded water over the past year due to its three top-selling medications (Eliquis, Opdivo, and Revlimid) losing market exclusivity this decade.While this wave of patent expirations may be worrisome at first glance, the drugmaker does have a solid plan in place to not only offset these future sales declines, but to keep its top line humming along all the way out to 2030. Namely, Bristol has multiple new drug launches planned over the next few years, several of which are for potential blockbuster medications.The long and short of it is that this isn't Bristol's first bout with the patent cliff. The company has lost market exclusivity for scores of blockbuster medications in the past. Yet it has always managed to hit on new growth products to create enormous value for long-term shareholders. Value-oriented investors, in turn, shouldn't hesitate to capitalize on the market's overreaction to the pharma titan's ongoing portfolio churn.A potential sleeping giantShares of the large-cap automaker General Motors (NYSE:GM) are currently trading at 7.43 times forward earnings. That's good for second place on Berkshire's list of cheapest stock holdings. The auto giant's stock has stagnated over the last year in response to the rise of electric vehicles, the market-wide disinterest in classic value stocks, and the upcoming interest rate hikes by the Federal Reserve that will surely make monthly payments more expensive for most car buyers.General Motors, though, may have some magic in it that the market has yet to fully appreciate. Last summer, the car giant announced an intriguing plan to invest heavily in electric vehicles, autonomous vehicles, and batteries. With a global commercial footprint and rock solid branding power, General Motors could prove to be a formidable competitor in these high-growth segments of the market.That said, General Motors' latent value proposition, albeit massive, may take a few years to win over investors. So, while this auto stock does come across as a compelling buy, this Buffett value stock will likely require a multi-year holding period to realize its full potential.Buffett's cheapest stock holdingWith its shares trading at 3.12 times forward earnings, Israeli generic and branded drug giant Teva Pharmaceutical Industries (NYSE:TEVA) is Berkshire's cheapest stock holding by a wide margin.The drugmaker's shares have lost three-quarters of their value over the last five years due to a series of unfortunate events. Specifically, Teva took on far too much debt to acquire Actavis' generic drug portfolio back in 2016, it didn't have another franchise-level medication waiting in the wings to replace the multiple sclerosis drug Copaxone following its loss of exclusivity, and it has been embroiled in a string of costly lawsuits.Teva's long-awaited turnaround, though, does seem to be coming into focus now, thanks to three key developments. First, the company has slowly built a well-rounded product portfolio that should return it to sustainable levels of growth soon. Second, its various legal problems ought to be resolved in the not-so-distant future. Third, Teva's ongoing deleveraging process has significantly improved the health of its balance sheet over the past few years. Teva's stock thus appears poised for a major rebound, perhaps as soon as this year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":519,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9098751730,"gmtCreate":1644241406257,"gmtModify":1676533903092,"author":{"id":"4088495159199840","authorId":"4088495159199840","name":"zbhtet","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088495159199840","authorIdStr":"4088495159199840"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9098751730","repostId":"1149534909","repostType":2,"isVote":1,"tweetType":1,"viewCount":800,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9000588762,"gmtCreate":1640231629985,"gmtModify":1676533510353,"author":{"id":"4088495159199840","authorId":"4088495159199840","name":"zbhtet","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088495159199840","authorIdStr":"4088495159199840"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000588762","repostId":"2193113147","repostType":4,"repost":{"id":"2193113147","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640213688,"share":"https://ttm.financial/m/news/2193113147?lang=&edition=fundamental","pubTime":"2021-12-23 06:54","market":"us","language":"en","title":"Wall St mints strong gains on rosy economic data, encouraging Omicron update","url":"https://stock-news.laohu8.com/highlight/detail?id=2193113147","media":"Reuters","summary":"* Tesla jumps as CEO Musk says he has sold 'enough' stock. * Pfizer rises as oral COVID-19 pill wins approval. Dec 22  - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.The S&P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of","content":"<p>* Consumer confidence index increases in December</p>\n<p>* U.S. Q3 economic growth revised slightly higher</p>\n<p>* Tesla jumps as CEO Musk says he has sold 'enough' stock</p>\n<p>* Pfizer rises as oral COVID-19 pill wins approval</p>\n<p>* Indexes up: Dow 0.74%, S&amp;P 1.02%, Nasdaq 1.18% </p>\n<p>Dec 22 (Reuters) - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.</p>\n<p>The S&amp;P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of Omicron and an otherwise strong year for equities.</p>\n<p>A South African study suggested reduced risks of hospitalization and severe disease in people infected with the Omicron variant versus the Delta one, but World Health Organization officials cautioned that it was too soon to draw firm conclusions.</p>\n<p>“We are still struggling for direction in the face of the Omicron outbreak, but in the past few days ... more and more evidence is building that the strain is potentially less severe than prior strains, specifically Delta, which bodes well for economic momentum in 2022,” said Mike Stritch, chief investment officer at BMO Wealth Management.</p>\n<p>The Dow Jones Industrial Average rose 261.19 points, or 0.74%, to 35,753.89, the S&amp;P 500 gained 47.33 points, or 1.02%, to 4,696.56 and the Nasdaq Composite added 180.81 points, or 1.18%, to 15,521.89.</p>\n<p>All major S&amp;P 500 sectors gained, with the consumer discretionary group up 1.7% and technology up 1.3%.</p>\n<p>Tesla Inc shares rose 7.5%, boosting the S&amp;P 500 and Nasdaq. Tesla Chief Executive Elon Musk said in an interview he has sold \"enough stock\" following several weeks of share sales by the billionaire.</p>\n<p>U.S. consumer confidence improved further in December, suggesting the economy would continue to expand in 2022. The survey from the Conference Board showed more consumers planned to buy a house and big-ticket items such as motor vehicles and major household appliances as well as go on vacation over the next six months.</p>\n<p>Other reports showed U.S. home sales increased for a third straight month in November, and that gross domestic product increased at a 2.3% annualized rate in the July-September quarter, revised up from the 2.1% rate estimated last month.</p>\n<p>In another encouraging development against the pandemic, the United States authorized Pfizer Inc's oral antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first at-home treatment for the coronavirus. Pfizer shares rose 1%.</p>\n<p>The benchmark S&amp;P 500 is now up 25% so far in 2021. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022 to rein in inflation.</p>\n<p>The market is \"certainly at an extended level of valuation,\" said Rick Meckler, partner at Cherry Lane Investments in New Vernon, New Jersey. “Next year is a more difficult picture, but if inflation is going to be part of the problem, I think investors will certainly choose stocks over bonds.”</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 3.17-to-1 ratio; on Nasdaq, a 1.65-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and no new lows; the Nasdaq Composite recorded 35 new highs and 99 new lows.</p>\n<p>About 8.6 billion shares changed hands in U.S. exchanges, below the 11.8 billion daily average over the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St mints strong gains on rosy economic data, encouraging Omicron update</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St mints strong gains on rosy economic data, encouraging Omicron update\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-23 06:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Consumer confidence index increases in December</p>\n<p>* U.S. Q3 economic growth revised slightly higher</p>\n<p>* Tesla jumps as CEO Musk says he has sold 'enough' stock</p>\n<p>* Pfizer rises as oral COVID-19 pill wins approval</p>\n<p>* Indexes up: Dow 0.74%, S&amp;P 1.02%, Nasdaq 1.18% </p>\n<p>Dec 22 (Reuters) - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.</p>\n<p>The S&amp;P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of Omicron and an otherwise strong year for equities.</p>\n<p>A South African study suggested reduced risks of hospitalization and severe disease in people infected with the Omicron variant versus the Delta one, but World Health Organization officials cautioned that it was too soon to draw firm conclusions.</p>\n<p>“We are still struggling for direction in the face of the Omicron outbreak, but in the past few days ... more and more evidence is building that the strain is potentially less severe than prior strains, specifically Delta, which bodes well for economic momentum in 2022,” said Mike Stritch, chief investment officer at BMO Wealth Management.</p>\n<p>The Dow Jones Industrial Average rose 261.19 points, or 0.74%, to 35,753.89, the S&amp;P 500 gained 47.33 points, or 1.02%, to 4,696.56 and the Nasdaq Composite added 180.81 points, or 1.18%, to 15,521.89.</p>\n<p>All major S&amp;P 500 sectors gained, with the consumer discretionary group up 1.7% and technology up 1.3%.</p>\n<p>Tesla Inc shares rose 7.5%, boosting the S&amp;P 500 and Nasdaq. Tesla Chief Executive Elon Musk said in an interview he has sold \"enough stock\" following several weeks of share sales by the billionaire.</p>\n<p>U.S. consumer confidence improved further in December, suggesting the economy would continue to expand in 2022. The survey from the Conference Board showed more consumers planned to buy a house and big-ticket items such as motor vehicles and major household appliances as well as go on vacation over the next six months.</p>\n<p>Other reports showed U.S. home sales increased for a third straight month in November, and that gross domestic product increased at a 2.3% annualized rate in the July-September quarter, revised up from the 2.1% rate estimated last month.</p>\n<p>In another encouraging development against the pandemic, the United States authorized Pfizer Inc's oral antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first at-home treatment for the coronavirus. Pfizer shares rose 1%.</p>\n<p>The benchmark S&amp;P 500 is now up 25% so far in 2021. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022 to rein in inflation.</p>\n<p>The market is \"certainly at an extended level of valuation,\" said Rick Meckler, partner at Cherry Lane Investments in New Vernon, New Jersey. “Next year is a more difficult picture, but if inflation is going to be part of the problem, I think investors will certainly choose stocks over bonds.”</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 3.17-to-1 ratio; on Nasdaq, a 1.65-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and no new lows; the Nasdaq Composite recorded 35 new highs and 99 new lows.</p>\n<p>About 8.6 billion shares changed hands in U.S. exchanges, below the 11.8 billion daily average over the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4007":"制药","BK4568":"美国抗疫概念",".IXIC":"NASDAQ Composite","PFE":"辉瑞",".DJI":"道琼斯","BK4533":"AQR资本管理(全球第二大对冲基金)","COMP":"Compass, Inc.","TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193113147","content_text":"* Consumer confidence index increases in December\n* U.S. Q3 economic growth revised slightly higher\n* Tesla jumps as CEO Musk says he has sold 'enough' stock\n* Pfizer rises as oral COVID-19 pill wins approval\n* Indexes up: Dow 0.74%, S&P 1.02%, Nasdaq 1.18% \nDec 22 (Reuters) - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.\nThe S&P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of Omicron and an otherwise strong year for equities.\nA South African study suggested reduced risks of hospitalization and severe disease in people infected with the Omicron variant versus the Delta one, but World Health Organization officials cautioned that it was too soon to draw firm conclusions.\n“We are still struggling for direction in the face of the Omicron outbreak, but in the past few days ... more and more evidence is building that the strain is potentially less severe than prior strains, specifically Delta, which bodes well for economic momentum in 2022,” said Mike Stritch, chief investment officer at BMO Wealth Management.\nThe Dow Jones Industrial Average rose 261.19 points, or 0.74%, to 35,753.89, the S&P 500 gained 47.33 points, or 1.02%, to 4,696.56 and the Nasdaq Composite added 180.81 points, or 1.18%, to 15,521.89.\nAll major S&P 500 sectors gained, with the consumer discretionary group up 1.7% and technology up 1.3%.\nTesla Inc shares rose 7.5%, boosting the S&P 500 and Nasdaq. Tesla Chief Executive Elon Musk said in an interview he has sold \"enough stock\" following several weeks of share sales by the billionaire.\nU.S. consumer confidence improved further in December, suggesting the economy would continue to expand in 2022. The survey from the Conference Board showed more consumers planned to buy a house and big-ticket items such as motor vehicles and major household appliances as well as go on vacation over the next six months.\nOther reports showed U.S. home sales increased for a third straight month in November, and that gross domestic product increased at a 2.3% annualized rate in the July-September quarter, revised up from the 2.1% rate estimated last month.\nIn another encouraging development against the pandemic, the United States authorized Pfizer Inc's oral antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first at-home treatment for the coronavirus. Pfizer shares rose 1%.\nThe benchmark S&P 500 is now up 25% so far in 2021. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022 to rein in inflation.\nThe market is \"certainly at an extended level of valuation,\" said Rick Meckler, partner at Cherry Lane Investments in New Vernon, New Jersey. “Next year is a more difficult picture, but if inflation is going to be part of the problem, I think investors will certainly choose stocks over bonds.”\nAdvancing issues outnumbered declining ones on the NYSE by a 3.17-to-1 ratio; on Nasdaq, a 1.65-to-1 ratio favored advancers.\nThe S&P 500 posted 15 new 52-week highs and no new lows; the Nasdaq Composite recorded 35 new highs and 99 new lows.\nAbout 8.6 billion shares changed hands in U.S. exchanges, below the 11.8 billion daily average over the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":495,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}